M C37 (Cetirizine 10 mg)

Pill imprint M C37 has been identified as Cetirizine hydrochloride 10 mg.

Cetirizine is used in the treatment of urticaria; hay fever and belongs to the drug class antihistamines. There is no proven risk in humans during pregnancy. Cetirizine 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M C37

Cetirizine hydrochloride 10 mg M C37
Cetirizine hydrochloride
Imprint:
M
C37
Strength:
10 mg
Color:
White
Size:
8.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Antihistamines
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-3637
Inactive Ingredients:
lactose anhydrous
silicon dioxide
hypromellose
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
triacetin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0597 UDL Laboratories Inc
35356-0085 Lake Erie Medical and Surgical Supply (repackager)
67544-1294 Prepak Systems Inc (repackager)
55289-0995 PDRX Pharmaceuticals Inc (repackager)
16590-0538 Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)